Spain· ES:1161108002
QTERN 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing saxagliptina + dapagliflozina, registered in Spain by Astrazeneca Ab.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- saxagliptina + dapagliflozina
- Manufacturer
- Astrazeneca Ab
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptina + dapagliflozina in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandQtern, FilmtablettenAstraZeneca AG
- United KingdomQtern 5mg/10mg tabletsAstraZeneca UK Ltd
- IrelandQtern 5 mg/10 mg film-coated tabletsAstraZeneca AB
- IcelandQternAstraZeneca AB*
- NetherlandsQtern, filmomhulde tablettenAstraZeneca AB
- PolandQternAstraZeneca AB
- SwedenQtern 5 mg/10 mg Filmdragerad tablettAstraZeneca AB
- United StatesDAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Qtern
- Liechtenstein · Qtern
- Norway · Qtern
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/84d6e9e2-f797-4153-a7cf-a0d72fe1a787 GET /v1/drugs/84d6e9e2-f797-4153-a7cf-a0d72fe1a787?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1470060883000}",
"nregistro": "1161108002",
"substance": "saxagliptina + dapagliflozina"
}See everything about saxagliptina + dapagliflozina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.